Presence of bacterial infection and duration of antibiotic therapy in patients with standardized sepsis detection in the emergency department

por Minderhoud, TC, Spruyt, C, Lomax, M, Huisman, S, Schuit, SCE, Levin, M-D
Publicado 2014

A new diagnostic work-up for defining anemia etiologies: a cohort study in patients ≥ 50 years in general practices

por Schop, A., Stouten, K., Riedl, J. A., van Houten, R. J., Leening, M. J. G., van Rosmalen, J., Bindels, P. J. E., Levin, M-D
Publicado 2020

PB1886: LONG-TERM TRENDS IN THE LOSS OF LIFE EXPECTANCY AFTER A DIAGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA: A POPULATION-BASED STUDY IN THE NETHERLANDS, 1989-2018

por Van Der Straten, L., Maas, C. C., Levin, M.-D., Visser, O., Posthuma, E. F., Doorduin, J. K., Langerak, A. W., Kater, A. P., Dinmohamed, A. G.
Publicado 2022

P933: DARATUMUMAB (D) IN COMBINATION WITH VD OR D-RD IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSIS OF CASTOR AND POLLUX STUDIES IN PATIENTS WITH EARLY OR LATE RELAP...

por Spencer, A., Moreau, P., Mateos, M.-V., Goldschmidt, H., Suzuki, K., Levin, M.-D., Sonneveld, P., Yoon, S.-S., Usmani, S. Z., Weisel, K., Reece, D., Ahmadi, T., Pei, H., Garvin Mayo, W., Gai, X., Carey, J., Carson, R., Dimopoulos, M. A.
Publicado 2022

Early-stage measurable residual disease dynamics and IGHV repertoire reconstitution during venetoclax and obinutuzumab treatment in chronic lymphocytic leukemia

por Hengeveld, P. J., Schilperoord-Vermeulen, J., van der Klift, M. Y., Dubois, J. M. N., Kolijn, P. M., Kavelaars, F. G., Rijken, M., Dobber, J. A., Nasserinejad, K., Kersting, S., Westerweel, P. E., Kater, A. P., Langerak, A. W., Levin, M-D.
Publicado 2023

Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?

por Bouwer, N. I., Steenbruggen, T. G., van Rosmalen, J., Rier, H. N., Kitzen, J. J. E. M., van Bekkum, M. L., Tije, A. J. Ten, de Jong, P. C., Drooger, J. C., Holterhues, C., Smorenburg, C. H., Kofflard, M. J. M., Boersma, E., Sonke, G. S., Levin, M.-D., Jager, A.
Publicado 2021

P905: IXAZOMIB-THALIDOMIDE-DEXAMETHASONE INDUCTION FOLLOWED BY IXAZOMIB OR PLACEBO MAINTENANCE IN NON-TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS; LONG-TERM RESUL...

por Groen, K., Seefat, M. R., van der Holt, B., Schjesvold, F. H., Stege, C. A., Levin, M.-D., Hansson, M., Leys, R. B., Regelink, J., Waage, A., Szatkowski, D., Axelsson, P., Do, T. H., Svirskaite, A., van der Spek, E., Haukas, E., Knut-Bojanowska, D., Ypma, P. F., Blimark, C., Mellqvist, U.-H., van de Donk, N. W., Sonneveld, P., Klostergaard, A., Vangsted, A. J., Abdilgaard, N., Zweegman, S.
Publicado 2022

P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 14...

por Groen, K., Seefat, M., Nasserinejad, K., Stege, C. A., van der Spek, E., Bilgin, Y. M., Kentos, A., Sohne, M., van Kampen, R. J., Ludwig, I., Thielen, N., Durdu-Rayman, N., de Graauw, N. C., van de Donk, N. W., de Waal, E. G., Vekemans, M.-C., Timmers, G. J., van der Klift, M., Soechit, S., Geerts, P. A., Silbermann, M. H., Oosterveld, M., Nijhof, I., Sonneveld, P., Klein, S. K., Levin, M.-D., Zweegman, S.
Publicado 2022

P12 HEALTH-RELATED QUALITY OF LIFE IN FRAIL AND INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DOSE-ADJUSTED MELPHALAN-PREDNISONE-BORTEZOMIB (MPV)

por Seefat, M.R., Stege, C.A.M., Timmers, G.J., Levin, M.D., Hoogendoorn, M., Ypma, P.F., Nijhof, I.S., Velders, G.A., Strobbe, L., Durdu-Rayman, N., Westerman, M., Davidis-van Schoonhoven, M.A., van Kampen, R.J.W., Beeker, A., Koster, A., Dijk, A.C., van de Donk, N.W.C.J., van der Spek, E., Leys, M.B.L., Silbermann, M.H., Groen, K., van der Burg-de Graauw, N.C.H.P., Sinnige, H.A.M., van der Hem, K.G., Levenga, T.H., Bilgin, Y.M., Sonneveld, P., Klein, S.K., Nasserinejad, K., Blommestein, H.M., Cucchi, D.G.J., Lissenberg-Witte, B.I., Zweegman, S.
Publicado 2023